Home > Request Information
Title:
Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Small Cell Lung Cancer
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh